VCEL VERICEL CORP
2026Q1 · CUSIP 92346J108 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
275
Δ holders QoQ
+2
Breadth percentile
Top 53%
Whale holders
143
Δ whales
+6
Inst. holding value
$1.8B
New positions
40
Closed positions
38
Price momentum (1Q)
-5.3%
Put / Call
3/2
Breadth history (34 quarters)
Past Lit Events & Aftermath 9 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q1 | Top 9% | -2.1% | +8.5% |
| 2023Q3 | Top 17% | +39.1% | +43.7% |
| 2023Q1 | Top 7% | -2.0% | +9.7% |
| 2022Q1 | Top 15% | +3.9% | -18.9% |
| 2021Q1 | Top 8% | -4.6% | -18.1% |
| 2020Q4 | Top 19% | -0.3% | -4.9% |
| 2018Q4 | Top 11% | -17.4% | -11.2% |
| 2018Q2 | Top 3% | +40.9% | +68.1% |
| 2018Q1 | Top 3% | -20.4% | +12.1% |
Options Sentiment
Put holders
3
QoQ: +1
Call holders
2
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
106.1
EPS (TTM)
$0.43
EPS YoY
+760.0%
Revenue (TTM)
$0.3B
Revenue YoY
+22.4%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)